Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis (Q43529695)

24 November 2017

Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis (English)

1 reference

24 November 2017

Francescopaolo Di Cello

1

1 reference

24 November 2017

Surajit Dhara

2

1 reference

24 November 2017

Alexandra C Hristov

3

1 reference

24 November 2017

Jeanne Kowalski

4

1 reference

24 November 2017

Ossama Elbahloul

5

1 reference

24 November 2017

Joelle Hillion

6

1 reference

24 November 2017

Sujayita Roy

7

1 reference

24 November 2017

Jules P P Meijerink

8

1 reference

24 November 2017

Stuart S Winter

9

1 reference

24 November 2017

Richard S Larson

10

1 reference

24 November 2017

David L Huso

11

1 reference

24 November 2017

Linda Resar

12

1 reference

24 November 2017

1 February 2013

1 reference

24 November 2017

1 reference

24 November 2017

54

1 reference

24 November 2017

8

1 reference

24 November 2017

1762-1768

1 reference

Acute lymphoblastic leukaemia

24 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Gene expression profiling in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Tumor suppressor genes in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Tumor suppression by Ink4a-Arf: progress and puzzles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Molecular biology of HMGA proteins: hubs of nuclear function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Roles of HMGA proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The high mobility group A1 gene: transforming inflammatory signals into cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The pattern of gene expression in human CD34(+) stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMG-I/Y, a new c-Myc target gene and potential oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMG-I/Y in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMGA2 participates in transformation in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Role of the INK4a locus in tumor suppression and cell mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Bethesda proposals for classification of lymphoid neoplasms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Recent advances in the therapeutic perspectives of Nutlin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.764422

10.3109/10428194.2013.764422

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference